A 12-MONTH, PROSPECTIVE, RANDOMIZED, SINGLE CENTER, OPEN LABEL PILOT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MYFORTIC(r) IN COMBINATION WITH TACROLIMUS AND THYMOGLOBULIN(r) IN EARLY CORTICOSTEROID WITHDRAWAL
2008 ◽
Vol 86
(Supplement)
◽
pp. 36
◽
Keyword(s):
2015 ◽
Vol 47
(3)
◽
pp. 617-621
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 25
(3)
◽
pp. S90
Keyword(s):
2004 ◽
Vol 50
(3)
◽
pp. P28
Keyword(s):
2012 ◽
Vol 66
(4)
◽
pp. AB183
Keyword(s):